Aoxing Pharmaceutical Company, Inc. (AOXG)

AOXG Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jan 21, 2025	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012
Market Capitalization	3	50	122	16	11	16
Market Cap Growth	-39.03%	-59.46%	666.04%	48.92%	-33.41%	-74.91%
Enterprise Value	47	69	148	45	31	29
Last Close Price	0.01	0.65	1.75	0.32	0.21	0.33
PE Ratio	-	24.03	22.24	-	-	-
PS Ratio	0.02	1.53	4.80	1.25	0.99	1.98
PB Ratio	0.03	2.74	12.14	-3.98	2.34	0.76
P/TBV Ratio	1.77	2.87	11.36	-	2.12	1.18
P/FCF Ratio	-	-	381.30	-	-	-
P/OCF Ratio	-	-	40.38	-	-	-
EV/Sales Ratio	1.57	2.14	5.82	3.53	2.83	3.57
EV/EBITDA Ratio	24.14	9.53	15.85	-	-	-
EV/EBIT Ratio	48.77	11.09	17.06	-	-	-
EV/FCF Ratio	-	-	463.08	-	-	-
Debt / Equity Ratio	1.53	1.41	3.00	-8.33	5.88	0.82
Debt / EBITDA Ratio	14.19	3.51	3.22	-	-	-
Debt / FCF Ratio	-	-	94.17	-	-	-
Asset Turnover	0.50	0.59	0.56	0.33	0.26	0.16
Inventory Turnover	2.32	2.56	2.09	2.88	2.06	1.98
Quick Ratio	0.51	0.48	0.27	0.18	0.32	0.35
Current Ratio	0.79	0.71	0.51	0.32	0.55	0.51
Return on Equity (ROE)	-7.56%	15.95%	192.21%	-3004.01%	-133.78%	-55.74%
Return on Assets (ROA)	1.00%	7.12%	11.93%	-5.36%	-9.65%	-1.42%
Return on Capital (ROIC)	1.30%	9.29%	15.61%	-6.84%	-11.65%	-1.62%
Earnings Yield	-266.69%	4.16%	4.50%	-51.51%	-156.90%	-98.37%
FCF Yield	-50.78%	-1.32%	0.26%	-50.15%	-81.76%	-12.92%
Buyback Yield / Dilution	-5.60%	-19.47%	-26.70%	-0.21%	-0.82%	-5.94%
Total Shareholder Return	-5.60%	-19.47%	-26.70%	-0.21%	-0.82%	-5.94%

Source: S&P Capital IQ. Standard template. Financial Sources.